New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry ...
2 hours ago
0
0
Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal suggests that this effect cannot be entirely explained by patients losing weight on the drug.
Sep 23, 2026
0
20
GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when patients stop treatment, they often regain their weight—primarily as fat.
Sep 21, 2026
0
131
Scroll through social media these days and you'll likely come across someone injecting themselves with a clear liquid, raving about how it's changed their body for the better, improved their recovery or maybe their skin.
Sep 17, 2026
0
6
Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that ...
Sep 13, 2026
0
27
For many people living with obesity, Wegovy and Mounjaro offer the possibility of substantial weight loss without surgery. Yet data from one private provider points to a troubling divide: Prescription rates of these drugs ...
Sep 9, 2026
0
6
The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain. The study was led by Chloe ...
Sep 7, 2026
0
13
A study published in Nature has shown that the GLP-1 drug semaglutide extended the lifespan of older, healthy mice by tempering the detrimental effects of aging. Researchers at the University of California, Berkeley, directly ...
Sep 2, 2026
0
28
Kentucky has one of the highest childhood obesity rates in the country, and the health consequences carry forward throughout life. That's one of the reasons researchers at the University of Kentucky are leading a groundbreaking ...
Aug 27, 2026
0
5
Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly used to treat diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research ...
Aug 24, 2026
0
17
